Overview

Analysis of Iliac Crest Biopsies From Patients Receiving Risedronate

Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
This study analysed and reported on the study data from three similar, risedronate studies, 1996052, 2003073, and 2003096. The objective of the study was to determine the differences in the iliac crest bone histomorphometry and bone quality in postmenopausal women who had received long term therapy with risedronate.
Details
Lead Sponsor:
Warner Chilcott
Collaborator:
Sanofi
Treatments:
Etidronic Acid
Risedronate Sodium
Risedronic Acid